COVID-19 Vaccine Janssen: European Medicines Agency’s assessment of very rare cases of unusual blood clots with low platelets continues

The European Medicines Agency is expediting this evaluation and currently expects to issue a recommendation next week. While its review is ongoing, it remains of the view that the benefits of the vaccine in preventing COVID-19 outweigh the risks of side effects.

Source:

European Medicines Agency